Remove 2017 Remove Disease Remove Structure Based Drug Design (SBDD)
article thumbnail

Sosei Heptares and Captor Therapeutics Enter Strategic Technology Collaboration Focused on Targeted GPCR Degradation as Novel Approach for Drug Design

The Pharma Data

Targeted protein degradation (TPD) is an approach whereby the body’s natural process for degrading proteins is diverted using small molecule drugs to eliminate disease-causing proteins. Captor’s Optigradeä platform is focused on improving the selectivity and performance of first-generation degrader drugs.